Indemnification by CRISPR. Each CRISPR Entity will jointly and severally indemnify, defend and hold harmless each Vertex Indemnified Party from and against any and all Liabilities that the Vertex Indemnified Party may be required to pay to one or more Third Parties to the extent resulting from or arising out of: 13.2.1. [***]; 13.2.2. [***]; except, in each case, to the extent Vertex is required to indemnify CRISPR pursuant to Section 13.1.
Appears in 3 contracts
Samples: Joint Development and Commercialization Agreement, Joint Development and Commercialization Agreement (Vertex Pharmaceuticals Inc / Ma), Joint Development and Commercialization Agreement (CRISPR Therapeutics AG)
Indemnification by CRISPR. Each CRISPR Entity will jointly and severally indemnify, defend and hold harmless Vertex, its Affiliates, Sublicensees, distributors and each of its and their respective employees, officers, directors and agents (each, a “Vertex Indemnified Party Party”) from and against any and all Liabilities that the Vertex Indemnified Party may be required to pay to one or more Third Parties to the extent resulting from or arising out of:
13.2.1. [***];
13.2.2. [***]; except, in each case, to the extent Vertex is required to indemnify CRISPR pursuant to Section 13.1.
Appears in 2 contracts
Samples: Strategic Collaboration, Option and License Agreement, Strategic Collaboration, Option and License Agreement (Vertex Pharmaceuticals Inc / Ma)
Indemnification by CRISPR. Each CRISPR Entity will jointly and severally indemnify, defend and hold harmless each Vertex Indemnified Party from and against any and all Liabilities that the Vertex Indemnified Party may be required to pay to one or more Third Parties to the extent resulting from or arising out of:
13.2.1. (a) [***];; or
13.2.2. (b) [***]; except, in each casecase ((a)-(b)), to the extent Vertex is required to indemnify CRISPR pursuant to Section 13.116.1.
Appears in 2 contracts
Samples: Joint Development and Commercialization Agreement (Vertex Pharmaceuticals Inc / Ma), Joint Development and Commercialization Agreement (CRISPR Therapeutics AG)